16 December 2025
Chemring Group PLC
PDMR share dealings
Chemring Group PLC ("Chemring" or "the Company") announces that, on 15 December 2025, an award of 42,838 deferred ordinary 1p shares in the capital of the Company previously granted to Sarah Ellard, a director of the Company, vested. The deferred share award was originally made in satisfaction of 40% of Mrs Ellard's annual bonus payment for the year ended 31 October 2022. 42,838 ordinary 1p shares were subsequently sold, of which 20,134 shares were sold by the Company on behalf of Mrs Ellard to cover tax and national insurance liabilities arising on vesting.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
|
Sarah Ellard | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Director/PDMR | ||||
| b)
| Initial notification /Amendment
| Initial | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Chemring Group PLC | ||||
| b)
| LEI
| 213800U9A54VQJ5P2J41 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Deferred award over ordinary 1p shares
GB00B45C9X44 | ||||
| b)
| Nature of the transaction
| Vesting of deferred award of shares in partial satisfaction of an annual bonus payment | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
|
| ||||
| e)
| Date of the transaction
| 15 December 2025 | ||||
| f)
| Place of the transaction
| Outside a trading venue | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
|
Sarah Ellard | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Director/PDMR | ||||
| b)
| Initial notification /Amendment
| Initial | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Chemring Group PLC | ||||
| b)
| LEI
| 213800U9A54VQJ5P2J41 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary 1p shares
GB00B45C9X44 | ||||
| b)
| Nature of the transaction
| Sale of ordinary 1p shares following vesting of deferred share award | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
|
| ||||
| e)
| Date of the transaction
| 15 December 2025 | ||||
| f)
| Place of the transaction
| XLON - London Stock Exchange | ||||
For further information:
| Chemring Group PLC | | |
| Sarah Ellard | Group Legal Director | +44 (0)7710 553757 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
